Share This Profile
Share this profile on Facebook.
Link to this profile on LinkedIn.
Tweet this profile on Twitter.
Email a link to this profile.
See other services through which you can share this profile.
This profile was last updated on 10/5/13  and contains information from public web pages and contributions from the ZoomInfo community.

Lynn E. Eschenbacher

Wrong Lynn E. Eschenbacher?

Assistant Director , Clinical Ser...

WakeMed Health & Hospitals
WakeMed
3000 New Bern Avenue
Raleigh, North Carolina 27610
United States

Company Description: WakeMed Health & Hospitals, one of the first hospital systems in the country, is a private, not-for-profit health care organization based in Raleigh, N.C. The...   more
Background

Employment History

Board Memberships and Affiliations

Education

  • PharmD
    University of Texas at Austin
  • MBA
    Fuqua School of Business at Duke University
  • Pharm.D.
  • M.B.A
19 Total References
Web References
Executive Committee
www.ashp.org, 5 Oct 2013 [cached]
Lynn E. Eschenbacher, PharmD, MBA
Lynn E. Eschenbacher is currently the Assistant Director of Clinical Services and PGYâ€1 Residency Director at WakeMed Health & Hospitals in Raleigh, North Carolina. She obtained her PharmD at University of Texas at Austin and then completed a pharmacy practice residency at Parkland Health & Hospitals in Dallas, Texas. Lynn has worked at Duke University Hospital as a clinical pharmacist, clinical coordinator and medication safety officer.
Additionally, she completed her MBA at the Fuqua School of Business at Duke University. Lynn was recently selected for the Circle of Excellence award at WakeMed for Market Development and Quality Outcomes. She is active at a state level as an elected executive committee member and an appointed education committee member and nationally as an ASHP House of Delegates representative, the Chair of the ASHP Section Advisory Group for Medication Safety and a member of the Clinical Leadership ASHP Section Advisory Group.
Lynn Eschenbacher can be e-mailed at sections@ashp.org.
...
Sitting left to right: Noelle RM Chapman, Lynn Eschenbacher, Jennifer Edwards Schultz
North Carolina Association of Pharmacists
www.ncpharmacists.org, 15 Dec 2010 [cached]
ASHP Delegate: Lynn Eschenbacher
Chronic Care Practice Forum
Mesothelioma: The Impact of the Drug Shortage on Mesothelioma Patients | Latest News
www.nationalasbestos.co.uk, 7 Sept 2011 [cached]
Even though the North Carolina hospitals compete for patient's business, Lynn Eschenbacher, assistant director for clinical services in WakeMed's pharmacy department, said, "The patient comes first, so we work with the other hospitals closely on this. We're all putting everything else aside and putting the patient first."
Lynn Eschenbacher, PharmD, ...
www.ihi.org, 22 Sept 2011 [cached]
Lynn Eschenbacher, PharmD, MBA, Assistant Director of Clinical Services and Director PGY-1 Pharmacy Residency Program, WakeMed Health and Hospitals
...
IHI's Frank Federico, the ISMP's Michael Cohen, and WakeMed's Lynn Eschenbacher are three pharmacy-trained improvers who've tapped their expertise on medication safety to come up with new strategies that can enable hospital staff to stay on top of the fast-moving drug shortage problem on a daily basis.
...
Learn how Lynn Eschenbacher's hospital system in particular is effectively dealing with the crisis.
"We use a checklist of all ...
www.ashpintersections.org, 12 Sept 2011 [cached]
"We use a checklist of all the pieces that have to be put in place when you make a change," said Lynn Eschenbacher, Pharm.D., MBA, the pharmacy's clinical manager. "We look at the data, determine how much drug we need, how much we have on hand, what the therapeutic alternatives are, and what our options are."
The process is driven by a committee that includes WakeMed's product buyer, business manager, operations manager, pharmacy director, medication safety officer, and Eschenbacher. "We meet to decide when to take a shortage to our P&T committee to get approval for a formulary change," she said.
The plan also accounts for technical changes that must be put in place, such as adding new products to the pharmacy order system or rotating items from automated dispensing cabinets on the patient care units back into the pharmacy, Eschenbacher added.
The Problem With Third Parties
Coping with shortages is a time-consuming, labor-intensive task, according to Eschenbacher. "On any given day, I can spend two to four hours working on a shortage," she said. "You have to figure out what the restrictions are for therapeutic substitution and decide if and when to go to a third party, such as a compounding pharmacy."
Buying from third parties is an expensive option. For example, during a shortage of prefilled syringes of epinephrine, WakeMed chose to contract with compounding pharmacies even though the system would not be reimbursed for the markup.
"We felt that safety outweighed the cost," Eschenbacher said. "The alternative would be mixing and pulling up a syringe in a crisis.
Other People with the name "Eschenbacher":
Other ZoomInfo Searches
Accelerate your business with the industry's most comprehensive profiles on business people and companies.
Find business contacts by city, industry and title. Our B2B directory has just-verified and in-depth profiles, plus the market's top tools for searching, targeting and tracking.
Atlanta | Boston | Chicago | Houston | Los Angeles | New York
Browse ZoomInfo's business people directory. Our professional profiles include verified contact information, biography, work history, affiliations and more.
Browse ZoomInfo's company directory. Our company profiles include corporate background information, detailed descriptions, and links to comprehensive employee profiles with verified contact information.